207 related articles for article (PubMed ID: 26416722)
1. MicroRNAs in obesity-associated disorders.
Abente EJ; Subramanian M; Ramachandran V; Najafi-Shoushtari SH
Arch Biochem Biophys; 2016 Jan; 589():108-19. PubMed ID: 26416722
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Regulatory Networks as Biomarkers in Obesity: The Emerging Role.
Zhang L; Miller D; Yang Q; Wu B
Methods Mol Biol; 2017; 1617():241-260. PubMed ID: 28540690
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: emerging roles in adipogenesis and obesity.
Peng Y; Yu S; Li H; Xiang H; Peng J; Jiang S
Cell Signal; 2014 Sep; 26(9):1888-96. PubMed ID: 24844591
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in obesity and the metabolic syndrome.
Heneghan HM; Miller N; Kerin MJ
Obes Rev; 2010 May; 11(5):354-61. PubMed ID: 19793375
[TBL] [Abstract][Full Text] [Related]
5. Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity.
Cruz KJC; de Oliveira ARS; Morais JBS; Severo JS; Marreiro PhD DDN
Nutrition; 2017 Mar; 35():28-35. PubMed ID: 28241987
[TBL] [Abstract][Full Text] [Related]
6. The clinical potential of adipogenesis and obesity-related microRNAs.
Zaiou M; El Amri H; Bakillah A
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):91-111. PubMed ID: 29170059
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.
Deiuliis JA
Int J Obes (Lond); 2016 Jan; 40(1):88-101. PubMed ID: 26311337
[TBL] [Abstract][Full Text] [Related]
8. Small non coding RNAs in adipocyte biology and obesity.
Amri EZ; Scheideler M
Mol Cell Endocrinol; 2017 Nov; 456():87-94. PubMed ID: 28412522
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance.
Murdolo G; Piroddi M; Luchetti F; Tortoioli C; Canonico B; Zerbinati C; Galli F; Iuliano L
Biochimie; 2013 Mar; 95(3):585-94. PubMed ID: 23274128
[TBL] [Abstract][Full Text] [Related]
10. A concise review of non-alcoholic fatty liver disease.
Than NN; Newsome PN
Atherosclerosis; 2015 Mar; 239(1):192-202. PubMed ID: 25617860
[TBL] [Abstract][Full Text] [Related]
11. Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease.
Xu L; Kitade H; Ni Y; Ota T
Biomolecules; 2015 Jul; 5(3):1563-79. PubMed ID: 26197341
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
14. Exercise Training-Induced Changes in MicroRNAs: Beneficial Regulatory Effects in Hypertension, Type 2 Diabetes, and Obesity.
Improta Caria AC; Nonaka CKV; Pereira CS; Soares MBP; Macambira SG; Souza BSF
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445764
[TBL] [Abstract][Full Text] [Related]
15. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
16. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
17. [Obesity, adipogenesis and insulin resistance].
Ros Pérez M; Medina-Gómez G
Endocrinol Nutr; 2011; 58(7):360-9. PubMed ID: 21778123
[TBL] [Abstract][Full Text] [Related]
18. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
19. Obesity, insulin resistance, NASH and hepatocellular carcinoma.
Yu J; Shen J; Sun TT; Zhang X; Wong N
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):483-91. PubMed ID: 23876851
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in fatty liver disease.
Sobolewski C; Calo N; Portius D; Foti M
Semin Liver Dis; 2015 Feb; 35(1):12-25. PubMed ID: 25632931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
